John M. Maraganore
2012
In 2012, John M. Maraganore earned a total compensation of $2.4M as Chief Executive Officer principal executive officer at Alnylam Pharmaceuticals, a 73% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,327 |
|---|---|
| Option Awards | $1,424,385 |
| Salary | $669,500 |
| Other | $8,798 |
| Total | $2,416,010 |
Maraganore received $1.4M in option awards, accounting for 59% of the total pay in 2012.
Maraganore also received $313.3K in non-equity incentive plan, $669.5K in salary and $8.8K in other compensation.
Rankings
In 2012, John M. Maraganore's compensation ranked 2,930th out of 11,487 executives tracked by ExecPay. In other words, Maraganore earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,930 out of 11,487 | 75th |
Division Manufacturing | 1,026 out of 4,252 | 76th |
Major group Chemicals And Allied Products | 232 out of 1,200 | 81st |
Industry group Drugs | 136 out of 922 | 85th |
Industry Pharmaceutical Preparations | 109 out of 697 | 84th |
Source: SEC filing on March 10, 2015.
Maraganore's colleagues
We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2012.
2012
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2012
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2012
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2012
Michael Mason
Alnylam Pharmaceuticals